Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

Published:2022-10 Issue: Volume:44 Page:60-68
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Udovicich Cristian,Callahan Jason,Bressel Mathias,Ong Wee Loon,Perera Marlon,Tran Ben,Azad Arun,Haran Shankar,Moon Daniel,Chander Sarat,Shaw Mark,Eapen Renu,Goad Jeremy,Lawrentschuk Nathan,Murphy Declan G.,Hofman Michael,Siva Shankar

Funder

Fulbright Australia

Peter MacCallum Foundation

Cancer Council Victoria

Kinghorn Foundation

Publisher

Elsevier BV

Subject

Urology

Reference42 articles.

1. National Cancer Institute. Cancer stat facts: kidney and renal pelvis cancer. https://seer.cancer.gov/statfacts/html/kidrp.html.

2. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study;Dabestani;World J Urol,2016